OTCMKTS:RBCL - RBC Life Sciences Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.21 0.00 (0.00 %) (As of 12/16/2018 01:08 PM ET)Previous Close$0.21Today's Range$0.21 - $0.2152-Week Range$0.1157 - $0.4711VolumeN/AAverage Volume15 shsMarket Capitalization$460,000.00P/E RatioN/ADividend YieldN/ABeta-1.03 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas. Receive RBCL News and Ratings via Email Sign-up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Miscellaneous nondurable goods Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RBCL Previous Symbol CUSIPN/A Webwww.rbclifesciences.com Phone972-893-4000 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares2,210,000Market Cap$460,000.00 OptionableNot Optionable RBC Life Sciences (OTCMKTS:RBCL) Frequently Asked Questions What is RBC Life Sciences' stock symbol? RBC Life Sciences trades on the OTCMKTS under the ticker symbol "RBCL." Has RBC Life Sciences been receiving favorable news coverage? Press coverage about RBCL stock has trended positive recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. RBC Life Sciences earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 8.0 out of 10, indicating that recent press coverage is very likely to have an impact on the stock's share price in the immediate future. Who are some of RBC Life Sciences' key competitors? Some companies that are related to RBC Life Sciences include Tenax Therapeutics (TENX), Health Discovery (HDVY), UPD (UPDC), Aoxing Pharmaceutical (AOXG), Skinvisible (SKVI), RXi Pharmaceuticals (RXII), Tauriga Sciences (TAUG), AdvanSource Biomaterials Corpration (ASNB), Escalon Medical (ESMC), Grown Rogue International (NVSIF), TearLab (TEAR), CardioGenics (CGNH), GlobeImmune (GBIM), Magna-Lab (MAGAA) and Taxus Cardium Pharmaceuticals Group (CRXM). Who are RBC Life Sciences' key executives? RBC Life Sciences' management team includes the folowing people: Mr. Clinton H. Howard, Founder & Chairman (Age 90)Mr. Steven E. Brown, Pres, Chief Exec. Officer & Director (Age 63)Mr. Douglas R. Wheeler, VP of Operations (Age 45)Mr. Don Clark, Chief Information OfficerMs. Carolyn Rachaner, VP of Marketing & Product Devel. How do I buy shares of RBC Life Sciences? Shares of RBCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is RBC Life Sciences' stock price today? One share of RBCL stock can currently be purchased for approximately $0.21. How big of a company is RBC Life Sciences? RBC Life Sciences has a market capitalization of $460,000.00. What is RBC Life Sciences' official website? The official website for RBC Life Sciences is http://www.rbclifesciences.com. How can I contact RBC Life Sciences? RBC Life Sciences' mailing address is 2301 CROWN COURT, IRVING TX, 75038. The company can be reached via phone at 972-893-4000 or via email at [email protected] MarketBeat Community Rating for RBC Life Sciences (OTCMKTS RBCL)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 28 (Vote Outperform)Underperform Votes: 34 (Vote Underperform)Total Votes: 62MarketBeat's community ratings are surveys of what our community members think about RBC Life Sciences and other stocks. Vote "Outperform" if you believe RBCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RBCL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/16/2018 by MarketBeat.com StaffFeatured Article: How is the S&P 500 index different from the DJIA?